Data / Federal rules / 2024-10602
Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
The Food and Drug Administration published this final rule in the Federal Register on May 15, 2024. It took effect on May 15, 2024.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
The Food and Drug Administration (FDA, the Agency, or we) is amending the animal drug regulations for labeling of new animal drugs included on FDA's Index of Legally Marketed Unapproved New Animal Drugs for Minor Species (indexed products) to reflect the 2018 statutory changes to the Federal Food, Drug, and Cosmetic Act (FD&C Act). This amendment is intended to ensure accuracy and clarity in the Agency's regulations. This amendment is nonsubstantive.
Key facts
- Document number
- 2024-10602
- Type
- Final rule
- Action
- Final rule; technical amendment
- Agency
- Health and Human Services Department; Food and Drug Administration
- Published
- May 15, 2024
- Takes effect
- May 15, 2024
- Dates
- This rule is effective May 15, 2024.
- Docket
- Docket No. FDA-2006-N-0239
- Code of Federal Regulations
- 21 CFR 516
- Topics
- Administrative practice and procedure; Animal drugs; Confidential business information; Reporting and recordkeeping requirements
- Pages
- 2
Other documents from the Food and Drug Administration
Everything from the Food and Drug Administration · Rules on administrative practice and procedure · Rules on animal drugs · Rules on confidential business information · Published in May 2024
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.